针刺治疗椎动脉型颈椎病眩晕的临床疗效观察  

Clinical observation of acupuncture in the treatment of vertigo ofvertebral artery cervical spondylopathy

作　　者：芦滢 李传游[2] 张敏[1] Lu Ying;Li Chuanyou;Zhang Min

机构地区：[1]南京中医药大学,江苏南京210023 [2]江苏省第二中医院,江苏南京210017

出　　处：《中医临床研究》2020年第24期73-74,87,共3页Clinical Journal Of Chinese Medicine

摘　　要：目的:探讨针刺治疗与口服甲磺酸倍他司汀治疗椎动脉型颈椎病眩晕的临床治疗效果比较。方法:选取江苏省第二中医院自2018年9月-2019年2月所收治的62例椎动脉型颈椎病眩晕患者,分为针刺组与口服甲磺酸倍他司汀组,通过评估疗效、治疗前后眩晕症状积分、治疗指数评判治疗效果。结果:针刺组总有效率93.55%(29/31),口服甲磺酸倍他司汀组总有效率87.10%(27/31);两组治疗前眩晕症状积分及治疗指数比较差异无统计学意义(P>0.05),治疗后及治疗前眩晕症状积分及治疗指数比较差异有统计学意义(P<0.05)。结论:针刺、口服甲磺酸倍他司汀治疗椎动脉型颈椎病眩晕均有疗效,但针刺治疗具有较为显著的疗效。Objective:To investigate the acupuncture therapy and oral Betahistine Mesilate Tablets in the treatment of vertigo of vertebral artery cervical spondylopathy.Method:Sixty-two cases of vertigo patients with vertebral artery cervical spondylopathy admitted to the Second Chinese Medicine Hospital of Jiangsu province from September 2018 to February 2019 were divided into the acupuncture group and the oral beitastine mesylate group.The therapeutic effect was evaluated by evaluating the curative effect,the score of vertigo symptoms before and after treatment,and the therapeutic index.Results:The total effective rate was 93.55%(29/31)in the acupuncture group and 87.10%(27/31)in the oral betastatin mesylate group.There were no statistically significant differences in the scores of vertigo symptoms and treatment index between the two groups before treatment(P>0.05),and there were statistically significant differences in the scores of vertigo symptoms and treatment index between the two groups after treatment(P<0.05).Conclusion:Acupuncture and oral betastatin mesylate are effective in the treatment of vertigo of vertebral artery cervical spondylopathy.However,acupuncture treatment has a relatively more significant effect.

关 键 词：针刺 椎动脉型颈椎病 眩晕 甲磺酸倍他司汀 

分 类 号：R246[医药卫生—针灸推拿学]